Empowering Progress and Realization in Life Sciences and Healthcare

With its unique global platform, NovaQuest Capital Management promotes the late-stage development of life-saving drugs and healthcare technologies and services in order to reduce the cost of healthcare, address unmet medical needs, improve safety, and enhance overall quality of life.

Our Strategies

Biopharma

Late-stage PRODUCT FINANCE™ investments in global biopharmaceutical products

Learn more

Animal Health

Partnerships with Animal Health Companies

Learn more

Private Equity

Partnerships with healthcare technology and services companies

Learn more

NovaQuest in the News

Hansa Biopharma announces $70 million non-dilutive product finance transaction with NovaQuest Capital Management to support continued development of the company’s antibody-cleaving enzyme technology platform across multiple therapeutic areas while extending the expected cash runway through 2024

TARGAN Secures $35M Series C Financing Led by Mountain Group Partners and NovaQuest Capital Management to Commercialize Novel Vaccine Delivery System for Poultry Industry

Phathom Pharmaceuticals Announces Revenue Interest Financing Agreement for Up to $260 Million in Non-Dilutive Capital

Stay Up to Date

Sign Up for Updates